No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS)
Kister, Ilya, Oh, Cheongeun, Douglas, Elizabeth A., Bacon, Tamar E., O'Shea, Isabella L., Parrotta, Erica H., Bouley, Andrew, Lathi, Ellen, Katz, Joshua
Published in Neurology. Clinical practice (01.10.2023)
Published in Neurology. Clinical practice (01.10.2023)
Get full text
Journal Article